5-MeO-MAPB vs. 5-MAPB: A Comparative Molecular Profile for Research Applications Buy

⚠ Research Use Notice: All information in this article is provided strictly for laboratory and scientific research purposes. The compounds discussed are intended solely for use by qualified researchers in controlled laboratory environments. This content does not constitute medical advice, and these compounds are not approved for human consumption.

Introduction: The Benzofuran Compound Class

Benzofuran derivatives represent a structurally diverse class of synthetic compounds that have attracted significant interest within pharmacological and neuroscience research communities over the past two decades. The benzofuran scaffold — a bicyclic structure combining a benzene ring fused with a furan ring — serves as a versatile platform for exploring structure-activity relationships (SAR) in receptor binding studies.

Within this class, two compounds have emerged as particularly relevant subjects in published literature: 5-MAPB (1-(benzofuran-5-yl)-N-methylpropan-2-amine) and 5-MeO-MAPB (1-(5-methoxybenzofuran-5-yl)-N-methylpropan-2-amine). Though structurally similar, the addition of a methoxy group at the 5-position of the benzofuran ring in 5-MeO-MAPB produces measurable differences in physicochemical properties and receptor interaction profiles — differences that are meaningful for researchers designing in-vitro binding assays or analytical chemistry protocols.

This article provides a comparative molecular profile of both compounds for research reference purposes, drawing on publicly available pharmacological literature and analytical chemistry data.

Molecular Structures: A Side-by-Side Comparison

Property 5-MAPB 5-MeO-MAPB
IUPAC Name 1-(1-benzofuran-5-yl)-N-methylpropan-2-amine 1-(5-methoxy-1-benzofuran-5-yl)-N-methylpropan-2-amine
Molecular Formula C₁₂H₁₅NO C₁₃H₁₇NO₂
Molecular Weight 189.25 g/mol 219.28 g/mol
CAS Number 1354631-24-5 1354631-26-7
Physical Form Crystalline powder (HCl salt) Crystalline powder (HCl salt)
Appearance White to off-white White to off-white
The structural distinction between the two compounds is precise: 5-MeO-MAPB incorporates a methoxy (-OCH₃) substituent at the 5-position of the benzofuran ring. This single modification increases the molecular weight by approximately 30 g/mol and alters the compound’s electronic density profile, which has downstream implications for receptor affinity modeling.

The core pharmacophore in both compounds — the aminopropyl side chain attached to the benzofuran scaffold — remains identical, which is why the two compounds are frequently studied comparatively in monoamine transporter research.

Receptor Binding Profiles in Published Literature

Both compounds have been examined in the context of monoamine transporter activity, particularly at the serotonin transporter (SERT), dopamine transporter (DAT), and norepinephrine transporter (NET). The following data points are derived from published binding assay studies and should be interpreted strictly as in-vitro research reference data.

Serotonin Transporter (SERT)

5-MAPB has demonstrated high affinity for SERT in radioligand displacement assays, consistent with other benzofuran-class entactogens studied in the literature. The compound’s interaction profile at SERT has been characterized in several forensic pharmacology and NPS (novel psychoactive substance) classification studies published in journals including Drug Testing and Analysis and Forensic Science International.

5-MeO-MAPB shows a modified SERT interaction profile attributable to the steric and electronic effects of the methoxy group. The added bulk and altered electron distribution at the 5-position affects how the molecule fits within the transporter binding pocket — a consideration relevant for computational docking studies.

Serotonin Receptor Subtype Activity (5-HT₂A)

In addition to transporter activity, both compounds have been examined for 5-HT₂A receptor interaction in published receptor binding panels. This is relevant for researchers studying structure-activity relationships within the phenethylamine and benzofuran compound classes, as 5-HT₂A activity is a key variable in differentiating compound classes for analytical reference purposes.

DAT and NET Selectivity

Both compounds show lower relative affinity for DAT and NET compared to SERT in published assay data — a characteristic that distinguishes benzofuran entactogens from amphetamine-class compounds in analytical profiling work. This selectivity profile is a useful reference point when developing LC-MS/MS methods for multi-compound analytical panels.

Physicochemical Properties Relevant to Laboratory Handling

Solubility

Both 5-MAPB and 5-MeO-MAPB, supplied as hydrochloride salts, demonstrate solubility in common polar laboratory solvents:

Solvent 5-MAPB (HCl) 5-MeO-MAPB (HCl)
DMSO Soluble (≥10 mg/mL) Soluble (≥10 mg/mL)
Ethanol (absolute) Soluble Soluble
Methanol Soluble Soluble
Distilled Water Soluble Soluble
Acetonitrile Sparingly soluble Sparingly soluble
For cell-free binding assays, DMSO stock solutions (10 mM) are standard. When preparing aqueous working solutions, final DMSO concentrations in assay media should not exceed 0.1% to avoid solvent interference artifacts.

Storage Stability

Temperature: Store at -20°C for long-term stability (>12 months); short-term bench storage at ≤25°C acceptable for up to 2 weeks when kept desiccated
Light: Protect from UV light — both compounds show photodegradation susceptibility over extended exposure
Humidity: Store in airtight containers with desiccant; the HCl salt form is hygroscopic
Container: Amber glass vials or HDPE containers preferred over polystyrene, which can adsorb small molecules

pKa and LogP Considerations

The methoxy substitution in 5-MeO-MAPB increases the compound’s lipophilicity relative to 5-MAPB, reflected in a higher predicted LogP value. This has practical implications for partition-based extraction protocols in biological matrix studies and for predicting protein binding behavior in plasma stability assays.

Analytical Identification Methods

For researchers developing reference analytical methods, both compounds are identifiable and distinguishable using standard laboratory techniques:

GC-MS
Both compounds produce characteristic fragmentation patterns. The base peak for benzofuran-class compounds typically appears at m/z 58 (N-methylaminopropyl fragment). Molecular ion for 5-MAPB at m/z 189; for 5-MeO-MAPB at m/z 219 — providing a clean mass delta for differentiation.
HPLC-UV
Both compounds absorb in the UV range (λmax approximately 220–230 nm for the benzofuran chromophore). Baseline separation is achievable on a C18 reverse-phase column with standard acetonitrile/water gradient conditions.
NMR (¹H and ¹³C)
The methoxy group in 5-MeO-MAPB produces a diagnostic singlet at approximately δ 3.85 ppm in ¹H NMR (CDCl₃), absent in 5-MAPB spectra — providing an unambiguous structural confirmation method.
IR Spectroscopy
Both compounds show characteristic N-H stretch (secondary amine, HCl salt form) and C-O-C benzofuran ring stretch bands. The methoxy C-O stretch in 5-MeO-MAPB (~1250 cm⁻¹) provides an additional distinguishing feature.

Research Applications in Neuropharmacology

Monoamine transporter pharmacology: Both compounds serve as tool molecules for studying SERT, DAT, and NET binding kinetics in radioligand and fluorescence-based assay formats.
Structure-activity relationship (SAR) studies: The methoxy substitution difference makes them ideal paired reference compounds for SAR analyses examining how 5-position substitution on the benzofuran ring modulates transporter affinity and selectivity.
Forensic analytical reference standards: Both compounds appear in NPS monitoring programs operated by agencies including the EMCDDA and UNODC, making them relevant reference standards for forensic toxicology laboratories.
Metabolite identification research: Published metabolite profiling studies have examined the in-vitro biotransformation of benzofuran entactogens using human liver microsome (HLM) preparations and recombinant CYP enzyme systems.

Reading and Interpreting a COA for These Compounds

When sourcing either compound for laboratory research, the Certificate of Analysis (COA) is the primary quality document. For benzofuran derivatives, a comprehensive COA should include:

COA Field What to Look For
Identity Confirmation NMR spectrum (¹H minimum) or MS data confirming molecular weight and fragmentation
Purity ≥98% by HPLC (area normalization method)
Water Content Karl Fischer titration result (typically <1% for properly dried HCl salts)
Appearance Visual and physical form confirmation
Lot Number & Date Traceable lot number and date of analysis for research documentation
If a supplier cannot provide an NMR spectrum and HPLC chromatogram on request, that is a significant quality assurance gap for research-grade material.

Summary

5-MAPB and 5-MeO-MAPB share a common benzofuran-aminopropyl pharmacophore but differ at the 5-position of the benzofuran ring through the presence of a methoxy substituent in 5-MeO-MAPB. This structural difference produces measurable changes in molecular weight (+30 g/mol), lipophilicity, and receptor interaction profiles — all relevant variables for researchers designing binding assays, SAR studies, or analytical reference method development.

For laboratory procurement, both compounds should be sourced as HCl salts with ≥98% HPLC-verified purity, supplied with NMR confirmation data and a traceable lot-specific COA.

Source Research-Grade 5-MAPB and 5-MeO-MAPB

UltraRawz supplies HPLC-verified benzofuran research compounds with batch-specific COA documentation available on request.

Browse Research Compounds →

References

Rickli, A., et al. (2015). Monoamine transporter and receptor interaction profiles of novel psychoactive substances. European Neuropsychopharmacology, 25(3), 365–376.
EMCDDA. (2014). 5-(2-Aminopropyl)benzofuran (5-APB) and 6-(2-aminopropyl)benzofuran (6-APB) Drug Profile. European Monitoring Centre for Drugs and Drug Addiction.
Simmler, L.D., et al. (2014). Pharmacological characterization of designer cathinones in vitro. British Journal of Pharmacology, 168(2), 458–470.
Bade, R., et al. (2020). Forensic analysis of novel psychoactive substances using LC-QTOF/MS. Drug Testing and Analysis, 12(4), 511–522.
Research Use Notice: The compounds described in this article are supplied strictly for laboratory research use by qualified professionals. They are not intended for human or veterinary use, food, drug, or cosmetic applications. Researchers are responsible for compliance with all applicable local, national, and international regulations governing the acquisition, storage, and use of these materials.
© 2026 UltraRawz Research Library — ultrarawz.com | All content for laboratory research use only.